Clinical Trial Update: Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing reduced-dose versus standard-dose irradiation for low-risk clinical target volume in nasopharyngeal carcinoma; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 3 | Status: RECRUITING